EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FMR1 Methylation Pattern and Repeat Expansion Screening in a Cohort of Boys with Autism Spectrum Disorders: Correlation of Genetic Findings with Clinical Presentations

Maria Dobre, Gisela Gaina iD, Alina Erbescu, Adelina Glangher, Florentina Ionela Linca iD, Doina Ioana, Emilia Maria Severin iD, Florina Rad, Mihaela Catrinel Iliescu, Sorina Mihaela Papuc iD, Mihail Eugen Hinescu iD, Aurora Arghir iD und 1 weitere

Genes · 2025

DOI: 10.3390/genes16080903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Maria Dobre und 12 weiteren Autor:innen. Beteiligte Einrichtung: Victor Babes National Institute of Pathology, 050096 Bucharest, Romania. Hauptthemen laut MEDLINE: Fragile X Messenger Ribonucleoprotein 1, Autism Spectrum Disorder, DNA Methylation, Trinucleotide Repeat Expansion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EEA Grant 2014-2021 Programme, UEFISCDI, Core Program within the National Research, Development, and Innovation Plan, 2022-2027, with the support of MCID, EEA Grant 2014–2021.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Autism spectrum disorders (ASDs) are neurodevelopmental conditions with early onset of clinical manifestations. ASD etiology is highly heterogeneous, with genetic factors being strong determinants of the behavioral problems and neurodevelopmental deficits. Fragile X syndrome (FXS) (OMIM #300624), caused by the transcriptional silencing of the FMR1 gene, represents the most common monogenic cause of autism. Our study included 226 boys with a diagnosis of ASD, for a systematic screening of genetic and epigenetic defects in the FMR1 gene promoter in a Romanian pediatric cohort.

Methods

The methods, methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) and triplet-primed PCR (TP-PCR)/melt curve analysis (MCA), were chosen for their ability to detect the methylation anomalies (the former) as well as repeat expansions in the FMR1 promoter (the latter).

Results

Both methods used in our screening generated concordant results, detecting FMR1 full mutation in 4 out of 226 patients (~1.8%). This yield is similar to data obtained in larger studies. Three out of four boys presented the typical clinical features, in correlation with genetic findings.

Conclusions

The combined use of MS-MLPA and TP-PCR/MCA-based assay was, in our experience, useful to fully describe the genetic defects responsible for FXS. A significant variability of clinical presentations was observed in our small group of children with FXS, from mild to severe intellectual disability and from atypical to characteristic dysmorphic features, as well as various behavioral problems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fragile X Messenger Ribonucleoprotein 1Autism Spectrum DisorderDNA MethylationTrinucleotide Repeat ExpansionHumansMaleChildChild, PreschoolPromoter Regions, GeneticFragile X SyndromeCohort StudiesAdolescentGenetic TestingMutation

Stichwörter der Autor:innen

Fragile X syndromeautismneurodevelopmental conditionstriplet repeat expansion

Substanzen

Fragile X Messenger Ribonucleoprotein 1FMR1 protein, human

Autor:innen und Institutionen

  • Victor Babes National Institute of Pathology, 050096 Bucharest, Romania.
  • Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Doctoral School, Faculty of Biology, University of Bucharest, 030018 Bucharest, Romania.
  • Prof. Dr. Alexandru Obregia Clinical Hospital of Pathology, 041914 Bucharest, Romania.
  • Faculty of Psychology and Education-Sciences, University of Bucharest, 050663 Bucharest, Romania.
  • Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania.

ORCID-Profile: Gisela Gaina, Florentina Ionela Linca, Emilia Maria Severin, Sorina Mihaela Papuc, Mihail Eugen Hinescu, Aurora Arghir

Förderung

  • EEA Grant 2014-2021 Programme, UEFISCDI
  • Core Program within the National Research, Development, and Innovation Plan, 2022-2027, with the support of MCID
  • EEA Grant 2014–2021
  • Core Program within the National Research, Development, and Innovation Plan
  • MCID

Zitieren

APA

Dobre, M., Gaina, G., Erbescu, A., Glangher, A., Linca, F. I., Ioana, D., Severin, E. M., Rad, F., Iliescu, M. C., Papuc, S. M., Hinescu, M. E., Arghir, A., & Budișteanu, M. (2025). FMR1 Methylation Pattern and Repeat Expansion Screening in a Cohort of Boys with Autism Spectrum Disorders: Correlation of Genetic Findings with Clinical Presentations. Genes. https://doi.org/10.3390/genes16080903

Vancouver

Dobre M, Gaina G, Erbescu A, Glangher A, Linca FI, Ioana D, et al. FMR1 Methylation Pattern and Repeat Expansion Screening in a Cohort of Boys with Autism Spectrum Disorders: Correlation of Genetic Findings with Clinical Presentations. Genes. 2025. doi:10.3390/genes16080903

BibTeX
@article{Dobre2025,
  author = {Dobre, Maria and Gaina, Gisela and Erbescu, Alina and Glangher, Adelina and Linca, Florentina Ionela and Ioana, Doina and Severin, Emilia Maria and Rad, Florina and Iliescu, Mihaela Catrinel and Papuc, Sorina Mihaela and Hinescu, Mihail Eugen and Arghir, Aurora and Budișteanu, Magdalena},
  title = {FMR1 Methylation Pattern and Repeat Expansion Screening in a Cohort of Boys with Autism Spectrum Disorders: Correlation of Genetic Findings with Clinical Presentations},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16080903}
}
Kostenlos starten →